Adicet Bio, Inc. - Common Stock (ACET)

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the second quarter of 2024.

These are the biotech stocks under $10 that are attractively valued and have potential catalysts in the form of positive clinical trials news

ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the first quarter of 2024.

Although speculation can be bad for your blood pressure, these compelling penny stocks have some strong endorsements.

ACET stock results show that Adicet Bio met analyst estimates for earnings per share the fourth quarter of 2023.

With the S&P 500 at record highs, betting on these high-risk stocks that could pay off is a tantalizing prospect at this time.

Unlock value in penny stocks amid bullish S&P 500 trends and shifting monetary policies, focusing on businesses with solid drivers

Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.

IN8bio (NASDAQ: INAB) is a biotechnology company that specializes in developing novel therapies based on gamma-delta T cells. Its innovative technology focuses on harnessing the potential of these cells to effectively target and eliminate cancer cells in both solid and hematological tumors.

Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.

Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<

Why Are Gamma-Delta T Cells Important In Fighting Cancer?